Company / Current Assets per Share
BridgeBio Pharma, Inc. Current Assets per Share History
FY2018-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Assets per Share
$4.20
FY2025
5-year range
$3.17 / $7.24
FY2021-FY2025
Trend
+2.0%
vs FY2024
Sector context
#146 of 210
Health Care
What the data says
At $4.20, BridgeBio Pharma, Inc.'s current assets per share ranks #146 of 210 in the Health Care sector. Current Assets per Share has fluctuated over the past 8 years, ranging from $3.17 in FY2023 to $7.24 in FY2021.
Based on SEC 10-K filings.
4.20 in FY2025 with a 5-year CAGR of -4.2%.
Improved from $3.17 to $4.20 over the past 2 years.
Health Care sector context is included.
Current Assets per Share over time
Growth rates
- 3-Year CAGR
- +4.1%
- 5-Year CAGR
- -4.2%
- 10-Year CAGR
- -
Sector benchmark
#146 of 210 in Health CareTop 70% of 210This company $4.20 Sector average $134.38
▼
-96.9% below sector average
Key checks
Key Insights
- In FY2025, current assets per share increased 2.0% year-over-year.
- Ranks #146 out of 210 companies in the Health Care sector.
- Peak current assets per share was recorded in FY2021.
- Lowest current assets per share in the period was in FY2023.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -4.56 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current Assets per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $4.20 | +2.0% |
| FY2024 | $4.12 | +29.8% |
| FY2023 | $3.17 | -14.9% |
| FY2022 | $3.72 | -48.5% |
| FY2021 | $7.24 | +39.2% |
| FY2020 | $5.20 | -15.8% |
| FY2019 | $6.18 | -14.3% |
| FY2018 | $7.21 | - |
| FY2017 | - | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026